SER
Serina Therapeutics Inc
2.00$
+0.0%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | 100.0% | – | – | – | – | – | |
| 182.8% | 0.2% | 500.0% | 111.8% | 17,250.0% | – | – | 12.3% | – | – | – | – | – | |
| -82.8% | 99.8% | -400.0% | -11.8% | -17,150.0% | – | – | 87.7% | – | – | – | – | – | |
| 1,896.6% | 29.4% | 22,120.0% | 3,125.5% | 17,250.0% | – | – | 2,424.6% | – | – | – | – | – | |
| 3,065.5% | 62.8% | 24,400.0% | 4,554.9% | 20,792.9% | – | – | 1,956.2% | – | – | – | – | – | |
| 4,962.1% | 92.0% | 46,020.0% | 7,580.4% | 20,792.9% | – | – | 4,368.5% | – | – | – | – | – | |
| -5,044.8% | 7.8% | -46,420.0% | -7,580.4% | -37,942.9% | – | – | -4,280.8% | – | – | – | – | – | |
| 344.8% | 5.7% | 1,980.0% | 474.5% | 114.3% | – | – | 6.9% | – | – | – | – | – | |
| 6,041.4% | 34.0% | -300,300.0% | 10,151.0% | 9,878.6% | – | – | -4,970.8% | – | – | – | – | – | |
| 41.4% | -0.1% | 1,980.0% | -52.9% | – | – | – | – | – | – | – | – | – | |
| 6,041.4% | 34.0% | -300,300.0% | 10,203.9% | 10,071.4% | – | – | -4,960.0% | – | – | – | – | – | |
| 6,569.0% | 39.9% | -296,080.0% | 10,737.3% | 10,392.9% | – | – | -4,951.5% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.